← Leaderboards
Liqin Zhao
University Of Kansas Lawrence
$4,859,507
Attributed
$6,863,305
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,863,305 · 6
By mechanism
R01$5,549,406 · 3
R21$993,185 · 2
P01$320,714 · 1
Top collaborators
- Teruna J. Siahaan9 shared
- Krzysztof Kuczera2 shared
Most similar at University Of Kansas Lawrence
Same institution · by research overlap
- Teruna J. Siahaan$8,220,545
- V Gustavo Blanco$11,554,263
- Gunda I. Georg$26,008,014
- Yang Zhang$9,269,576
- David K Johnson$383,496
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseBrainMediatingMouse ModelMolecularAffectSynapsesGenesOutcomes ResearchCognitive FunctionInsightApolipoprotein EAging BrainSuccessAllelesApolipoprotein E-3High RiskMetabolismGlucoseBiologicalAmyloidPreventProteins
Grant awards (20)
Reshaping ApoE4 and Alzheimer's Brains with ApoE2$578,222
R01 · FY2025 · AG · contact PI
A Novel Method to Enhance Drug Delivery to the Brain$443,442
R01 · FY2025 · AG
Reshaping ApoE4 and Alzheimer's Brains with ApoE2$71,016
R01 · FY2025 · AG · contact PI
Reshaping ApoE4 and Alzheimer's Brains with ApoE2$764,401
R01 · FY2024 · AG · contact PI
A Novel Method to Enhance Drug Delivery to the Brain$487,741
R01 · FY2024 · AG
Reshaping ApoE4 and Alzheimer's Brains with ApoE2$17,755
R01 · FY2024 · AG · contact PI
Reshaping ApoE4 and Alzheimer's Brains with ApoE2$585,478
R01 · FY2023 · AG · contact PI
Sporadic Alzheimer's Disease: A Bioenergetic Etiology?$369,924
R01 · FY2023 · AG · contact PI
Reshaping ApoE4 and Alzheimer's Brains with ApoE2$168,213
R01 · FY2023 · AG · contact PI
Reshaping ApoE4 and Alzheimer's Brains with ApoE2$580,933
R01 · FY2022 · AG · contact PI
Sporadic Alzheimer's Disease: A Bioenergetic Etiology?$370,195
R01 · FY2022 · AG · contact PI
Sporadic Alzheimer's Disease: A Bioenergetic Etiology?$370,453
R01 · FY2021 · AG · contact PI
Sporadic Alzheimer's Disease: A Bioenergetic Etiology?$370,699
R01 · FY2020 · AG · contact PI
Sporadic Alzheimer's Disease: A Bioenergetic Etiology?$370,934
R01 · FY2019 · AG · contact PI
ApoE, Energy, and Synaptic V-ATPase$221,898
R21 · FY2019 · AG · contact PI
Role of Clusterin in Brain Mitochondria$184,331
R21 · FY2018 · AG · contact PI
ApoE, Energy, and Synaptic V-ATPase$184,251
R21 · FY2018 · AG · contact PI
Role of Clusterin in Brain Mitochondria$180,343
R21 · FY2018 · AG · contact PI
Role of Clusterin in Brain Mitochondria$222,362
R21 · FY2017 · AG · contact PI
ANALYTIC CORE$320,714
P01 · FY2011 · AG · contact PI